Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vicarious Surgical ( (RBOT) ) has shared an update.
On September 8, 2025, Vicarious Surgical updated its investor presentation, which will be used by senior management in interactions with investors and analysts, including at the H.C. Wainwright 27th Annual Global Investment Conference. The presentation highlights the company’s strategy to redefine robotic surgery by expanding access to millions of procedures beyond the reach of existing systems, focusing on areas like ventral hernia repair where traditional robotic systems face limitations. This move is expected to enhance Vicarious Surgical’s market positioning by addressing a large portion of abdominal procedures that remain non-robotic, potentially leading to better patient outcomes and operational efficiency.
The most recent analyst rating on (RBOT) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Vicarious Surgical stock, see the RBOT Stock Forecast page.
Spark’s Take on RBOT Stock
According to Spark, TipRanks’ AI Analyst, RBOT is a Underperform.
Vicarious Surgical’s stock score reflects significant financial challenges as a pre-revenue company with high cash burn, offset by a moderately stable balance sheet. Technical analysis indicates bearish sentiment, compounded by valuation challenges due to negative earnings. While the earnings call showed strategic advancements, supply chain delays and NYSE compliance issues pose risks. Successful clinical trials and improved cash management will be critical for future performance.
To see Spark’s full report on RBOT stock, click here.
More about Vicarious Surgical
Vicarious Surgical Inc. operates in the medical technology industry, focusing on developing advanced robotic systems for minimally invasive surgeries. Their primary product, the Vicarious Surgical System, aims to provide open-like access through a single incision, addressing limitations of current robotic systems and expanding the market for robotic surgery.
Average Trading Volume: 29,302
Technical Sentiment Signal: Sell
Current Market Cap: $33.87M
For a thorough assessment of RBOT stock, go to TipRanks’ Stock Analysis page.